The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
If you are wondering whether Abbott Laboratories at around US$87.41 is a bargain or a value trap, it helps to step back and ...
Abbott Laboratories (NYSE:ABT) was one of the stocks on which Jim Cramer shared his take, explaining that dot-com analogies ...
Zacks Investment Research on MSN
Abbott Laboratories (ABT) is attracting investor attention: Here is what you should know
Abbott (ABT) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...
A Missouri appellate court has upheld a $495 million verdict against Abbott Laboratories in a case over whether its formula for premature infants caused a girl to become seriously ill.
Abbott Laboratories must pay $53 million in compensatory damages in four cases in which Chicago area babies developed a dangerous intestinal disease after consuming the company’s formula for premature ...
Monday - Friday, 6:00 - 7:00 PM ET CNBC's Jim Cramer on Friday evaluated the stock of Abbott Laboratories, a healthcare company that's been weighed down by ongoing litigation for several months.
Abbott Laboratories (NYSE:ABT) is preparing to release its quarterly earnings on Thursday, 2025-07-17. Here's a brief overview of what investors should keep in mind before the announcement. Analysts ...
Abbott Laboratories trades at 17.7x forward earnings, the lowest valuation multiple in a decade. Read why I rate ABT stock a ...
CHICAGO, April 10 (Reuters) - A jury in Chicago on Friday said Abbott Laboratories (ABT.N), opens new tab must pay $70 million in damages to a group of families that had accused the company of failing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results